CyFlow™ CD19 PerCP

CyFlow™ CD19 PerCP
Laser: Blue, Green
Target Species: Human
Antigen: CD19
Field of Interest: Immunophenotyping
Clone: 4G7
Regulatory Status: RUO
Alternative Name: B4
Application: Flow cytometry
Format/Fluorochrome: PerCP
Species of Origin: Mouse
Clonality: monoclonal
Emission Maximum: 678 nm
Excitation Maximum: 482 to 490 nm
Isotype: IgG1
Product number: CQ506168

For Research Use Only

$265.00 USD*

Price excludes any applicable taxes plus shipping costs

Concentration Quantity 100 tests Volume 1.0 mL Immunogen Human Chronic... more
CyFlow™ CD19 PerCP
Concentration
Quantity100 tests
Volume1.0 mL
ImmunogenHuman Chronic Lymphocytic Leukemia (CLL) cells
Background InformationCD19 is a transmembrane glycoprotein of Ig superfamily expressed by B cells from the time of heavy chain rearrangement until plasma cell differentiation. It forms a tetrameric complex with CD21 (complement receptor type 2), CD81 (TAPA-1) and Leu13. Together with BCR (B cell antigen receptor), this complex signals to decrease B cell treshold for activation by the antigen. Besides being signal-amplifying coreceptor for BCR, CD19 can also signal independently of BCR coligation and it turns out to be a central regulatory component upon which multiple signaling pathways converge. Mutation of the CD19 gene results in hypogammaglobulinemia, whereas CD19 overexpression causes B cell hyperactivity.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 10·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Reinherz EL, Haynes BF, Nadler LM, Bernstein ID: Leukocyte Typing II, Volume 1 Human T Lymphocytes. Springer·Verlag,·New·York. 1986; 1:1‑549. <·PMID:·Springer·8587-5·> | Muench MO, Roncarolo MG, Namikawa R: Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood. 1997·Feb·15; 89(4):1364‑75. <·PMID:·9028960·> | Stockmeyer B, Dechant M, van Egmond M, Tutt AL, Sundarapandiyan K, Graziano RF, Repp R, Kalden JR, Gramatzki M, Glennie MJ, van de Winkel JG, Valerius T: Triggering Fc alpha‑receptor I (CD8{09} recruits neutrophils as effector cells for CD20‑directed antibody therapy. J·Immunol. 2000·Nov·15; 165(10):5954‑61. <·PMID:·11067958·> | Dubois B, Massacrier C, Caux C: Selective attraction of naive and memory B cells by dendritic cells. J·Leukoc·Biol. 2001·Oct; 70(4):633‑41. <·PMID:·11590201·> | Basu S, Lynne CM, Ruiz P, Aballa TC, Ferrell SM, Brackett NL: Cytofluorographic identification of activated T‑cell subpopulations in the semen of men with spinal cord injuries. J·Androl. 2002·Jul-Aug; 23(4):551‑6. <·PMID:·12065463·> | Porcellini S, Vallanti G, Nozza S, Poli G, Lazzarin A, Tambussi G, Siccardi AG, Grassi F: Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL‑2 administration. AIDS. 2003·Jul·25; 17(11):1621‑30. <·PMID:·12853744·> | Treusch M, Vonthein R, Baur M, Günaydin I, Koch S, Stübiger N, Eckstein AK, Peter HH, Ness T, Zierhut M, Kötter I: Influence of human recombinant interferon‑alpha2a (rhIFN‑alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology·(Oxford). 2004·Oct; 43(10):1275‑82. <·PMID:·15252211·> | Köller M, Zwölfer B, Steiner G, Smolen JS, Scheinecker C: Phenotypic and functional deficiencies of monocyte‑derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int·Immunol. 2004·Nov; 16(11):1595‑604. <·PMID:·15381672·> | Martino V, Tonelli R, Montemurro L, Franzoni M, Marino F, Fazzina R, Pession A: Down‑regulation of MLL‑AF9, MLL and MYC expression is not obligatory for monocyte‑macrophage maturation in AML‑M5 cell lines carrying t(9: 11)(p22: q23). Oncol·Rep. 2006·Jan; 15(1):207‑11. <·PMID:·16328057·> | Andersen P, Pedersen MW, Woetmann A, Villingshøj M, Stockhausen MT, Odum N, Poulsen HS: EGFR induces expression of IRF‑1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells. Int·J·Cancer. 2008·Jan·15; 122(2):342‑9. <·PMID:·17918184·>

Article successfully added.